Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism

Journal of Orthopaedic Research

Volumn 25, Issue 11, 2007, Pages 1454-1464

  Friedl, Gerald ^a   Turner, Russell T ^b   Evans, Glenda L ^c   Dobnig, Harald ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b OREGON STATE UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Aging; Bone formation; Bone remodeling; Osteoporosis; Trabecular architecture

Indexed keywords

MATRIX PROTEIN; MESSENGER RNA; PARATHYROID HORMONE;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE TURNOVER; CANCELLOUS BONE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GROUPS BY AGE; HORMONAL THERAPY; MINERAL METABOLISM; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS; PRIORITY JOURNAL; RAT; TRABECULAR BONE; TREATMENT OUTCOME;

AGING; ANIMALS; BODY WEIGHT; BONE REMODELING; CALCIFICATION, PHYSIOLOGIC; DRUG ADMINISTRATION SCHEDULE; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FEMUR; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOGENESIS; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RNA, MESSENGER;

EID: 36749008537     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20433     Document Type: Article

References (45)

1. Neer RM, Arnaud CD, Zanchetta JR, et al. 2001. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441.
2. Andreassen TT, Ejersted C, Oxlund H. 1999. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14:960-968.
3. Seebach C, Skripitz R, Andreassen TT, et al. 2004. Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats. J Orthop Res 22:472-478.
4. Skripitz R, Bohling S, Ruther W, et al. 2005. Stimulation of implant fixation by parathyroid hormone (1-34) - a histomorphometric comparison of PMMA cement and stainless steel. J Orthop Res 23:1266-1270.
5. Pfeilschifter J, Laukhuf F, Muller-Beckmann B, et al. 1995. Parathyroid hormone increases the concentration of insulin-like growth factor-I and transforming growth factor beta 1 in rat bone. J Clin Invest 96:767-774.
6. McCarthy TL, Centrella M, Canalis E. 1989. Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124:1247-1253.
7. Tanaka H, Quarto R, Williams S, et al. 1994. In vivo and in vitro effects of insulin-like growth factor-I (IGF-I) on femoral mRNA expression in old rats. Bone 15:647-653.
8. Spencer EM, Liu CC, Si EC, et al. 1991. In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats. Bone 12:21-26.
9. Dobnig H, Turner RT. 1995. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638.
10. Leaffer D, Sweeney M, Kellerman LA, et al. 1995. Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH- (1-34). Endocrinology 136:3624-3631.
11. Kostenuik PJ, Harris J, Halloran BP, et al. 1999. Skeletal unloading causes resistance of osteoprogenitor cells to parathyroid hormone and to insulin-like growth factor-I. J Bone Miner Res 14:21-31.
12. Ma Y, Zeng Q, Donley D, et al. 2006. Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res 21:855-864.
13. Martin EA, Ritman EL, Turner RT. 2003. Time course of epiphyseal growth plate fusion in rat tibiae. Bone 32:261-267.
14. Dobnig H, Turner RT. 1997. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 138:4607-4612.
15. Riond JL. 1993. Modulation of the anabolic effect of synthetic human parathyroid hormone fragment-(I-34) in the bone of growing rats by variations in the dosage regimen. Clin Sci (Lond) 85:223-228.
16. Westerlind KC, Wakley GK, Evans GL, et al. 1993. Estrogen does not increase bone formation in growing rats. Endocrinology 133:2924-2934.
17. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guamdinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
18. Turner RT, Backup P, Sherman PJ, et al. 1992. Mechanism of action of estrogen on intramembranous bone formation: regulation of osteoblast differentiation and activity. Endocrinology 131:883-889.
19. Turner RT. 1994. Cancellous bone turnover in growing rats: time-dependent changes in association between calcein label and osteoblasts. J Bone Miner Res 9:1419-1424.
20. Parfitt AM, Drezner MK, Glorieux FH, et al. 1987. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595-610.
21. Cavolina JM, Evans GL, Harris SA, et al. 1997. The effects of orbital spaceflight on bone histomorphometry and messenger ribonucleic acid levels for bone matrix proteins and skeletal signaling peptides in ovariectomized growing rats. Endocrinology 138:1567-1576.
22. Turner CH, Takano Y, Owan I. 1995. Aging changes mechanical loading thresholds for bone formation in rats. J Bone Miner Res 10:1544-1549.
23. Ikeda T, Nagai Y, Yamaguchi A, et al. 1995. Age-related reduction in bone matrix protein mRNA expression in rat bone tissues: application of histomorphometry to in situ hybridization. Bone 16:17-23.
24. Hock JM, Hummert JR, Boyce R, et al. 1989. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo. J Bone Miner Res 4:449-458.
25. Cosman F, Nieves J, Woelfert L, et al. 1998. Alendronate does not block the anabolic effect of PTH in postmenopausal osteoporotic women. J Bone Miner Res 13:1051-1055.
26. Horner A, Kemp P, Summers C, et al. 1998. Expression and distribution of transforming growth factor-beta isoforms and their signaling receptors in growing human bone. Bone 23:95-102.
27. Bonewald LF, Mundy, GR. 1990. Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res 250:261-276.
28. Taniguchi Y, Tanaka T, Gotoh K, et al. 1993. Transforming growth factor beta 1-induced cellular heterogeneity in the periosteum of rat parietal bones. Calcif Tissue Int 53:122-126.
29. Kwok S, Qin, L, Partridge NC, et al. 2005. Parathyroid hormone stimulation and PKA signaling of latent transforming growth factor-beta binding protein-1 (LTBP-1) mRNA expression in osteoblastic cells. J Cell Biochem 95:1002-1011.
30. Lane NE, Thompson JM, Strewler GJ, et al. 1995. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats. J Bone Miner Res 10:1470-1477.
31. Silverber S, Bilezikian J. 2001. Clinical presentation of primary hyperparathyroidism in the United States. In: Bilezikian JP, Marcud R, Levine MA, editors. The parathyroids: basic and clinical concepts. 2nd ed. San Diego, CA: Academic Press; p 349-360.
32. Turner RT, Evans GL, Lotinun S, et al. 2007. Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats. J Bone Miner Res 22:64-71.
33. Leaffer D, Sweeney M, Avnur Z, et al. 1994. PTH, PTHrP, and an analog, RS-66271, increase the osteoblast population of the vertebrae of ovariectomized rats after 5 days of dosing (abstract). J Bone Miner Res 9:S304.
34. Power RA, Iwaniec UT, Magee KA, et al. 2004. Basic fibroblast growth factor has rapid bone anabolic effects in ovariectomized rats. Osteoporos Int 15:716-723.
35. Boppart MD, Kimmel DB, Yee JA, et al. 1998. Time course of osteoblast appearance after in vivo mechanical loading. Bone 23:409-415.
36. Jilka RL, Weinstein RS, Bellido T, et al. 1999. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104:439-446.
37. Qi H, Li M, Wronski TJ. 1995. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats. J Bone Miner Res 10:948-955.
38. Turner RT, Evans GL, Cavolina JM, et al. 1998. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats. Endocrinology 139:4086-4091.
39. Wronski TJ, Pun S, Liang H. 1999. Effects of age, estrogen depletion, and parathyroid hormone treatment on vertebral cancellous wall width in female rats. Bone 25:465-468.
40. Kneissel M, Boyde A, Gasser JA. 2001. Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). Bone 28: 237-250.
41. Hock JM, Gera I. 1992. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 7:65-72.
42. Silverberg SJ, Shane E, Jacobs TP, et al. 1999. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341:1249-1255.
43. Mitlak BH, Williams DC, Bryant HU, et al. 1992. Intermittent administration of bovine PTH-(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats. J Bone Miner Res 7:479-484.
44. Turner RT, Evans GL, Wakley GK. 1993. Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption. J Bone Miner Res 8:359-366.
45. Turner RT, Spelsberg TC. 1991. Correlation between mRNA levels for bone cell proteins and bone formation in long bones of maturing rats. Am J Physiol 261:E348-E353.